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Abstract 
 
Nucleoside diphosphate kinases (NDPKs) are multi-functional proteins encoded by the NME (Non 
Metastatic cells) genes, also called NM23. NDPKs catalyze the transfer of J-phosphate from 
nucleoside triphosphates to nucleoside diphosphates by a ping-pong mechanism involving the 
formation of a high energy phospho-histidine intermediate.  Growing evidence shows that 
nucleoside diphosphate kinases (NDPKs), particularly NDPK-B, can additionally act as a protein 
histidine kinase.  Protein kinases and phosphatases that regulate reversible O-phosphorylation of 
serine, threonine and tyrosine residues have been studied extensively in many organisms.  
Interestingly, other phosphoamino acids histidine, lysine, arginine, aspartate, glutamate and 
cysteine exist in abundance but remain understudied due to the paucity of suitable methods and 
antibodies.  The N-phosphorylation of histidine by histidine kinases via the two- or multi-
component signaling systems is an important mediator in cellular responses in prokaryotes and 
lower eukaryotes, like yeast, fungi, and plants. However, in vertebrates knowledge of 
phosphohistidine signaling has lagged far behind and the identity of the protein kinases and protein 
phosphatases involved is not well established.  This article will therefore provide an overview of 
our current knowledge on protein histidine phosphorylation particularly the role of nm23 as a 
protein histidine kinase. 
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Protein Serine, Threonine and Tyrosine Phosphorylation 
 
In animals the most well recognized forms of protein phosphorylation are those in which the 
phosphoserine, phosphothreonine or phosphotyrosine are formed on the target protein in reactions 
catalyzed by Ser/Thr or Tyr protein kinases. The phosphorus of the phosphoryl group is bonded to 
the hydroxyl oxygen in these phosphoamino acids, which are thus phosphoesters (Fig. 1). These 
reactions involve the transfer of the gamma-phosphoryl group from ATP to the hydroxyl oxygen of 
the side chain of Ser, Thr or Tyr. The phosphorylation of target proteins results in a change in 
protein activity through conformational changes in the protein structure induced by the insertion of 
the relatively large, negatively charged phosphoryl group. Alternatively, the phosphoamino acid 
acts as a docking site to allow other proteins to bind to the phosphoprotein (e.g. proteins containing 
SH2 domains can bind via these domains to phosphoproteins containing phosphotyrosine). Many 
aspects of cellular function in animals are regulated by signaling pathways involving Ser/Thr and 
Tyr protein kinases. In addition these pathways also involve phosphoprotein phosphatases which 
catalyze the hydrolysis of the phosphoamino acids in phosphoproteins, thus reversing the effects of 
phosphorylation on protein activity and protein-protein interaction. It is only relatively recently that 
similar protein kinases and phosphoprotein phosphatases were found to occur in bacteria (for 
reviews see Pereira et al. 2011 and Chao et al. 2014)1, 2. 
 
Protein Histidine Phosphorylation 
(i) Bacteria, fungi and plants 
Before the discovery of the occurrence of Ser/Thr and Tyr protein kinases in bacteria it was thought 
that the predominant form of protein phosphorylation to occur in these organisms was histidine 
phosphorylation, catalyzed by protein histidine kinases.   
In phosphohistidine, the phosphorus of the phosphoryl group is bonded to one of the nitrogens in 
the imidazole ring of the side chain of histidine to form a phosphoramidate (Fig. 1). Since the 
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imidazole ring of histidine contains two nitrogens, there are two possible isomers of 
phosphohistidine, 1-phosphohistidine and 3-phosphohistidine, both of which occur biologically 
(Fig. 1).   
In bacteria and lower eukaryotes, protein histidine kinases are parts of the two-component histidine 
kinase systems where the histidine kinase is usually part of a membrane-bound receptor, which is 
activated on receipt of an extracellular stimulus by the sensor domain. This results in the 
autophosphorylation of a conserved histidine residue in the dimerisation domain of the receptor (see 
Fig. 2 in Attwood, 20133). The phosphoryl group is then transferred from the phosphohistidine to a 
conserved aspartate residue in the regulatory domain of a response regulator protein in a reaction 
catalyzed by this protein (Fig. 1). This activates the response regulator protein, which is most 
commonly a transcription factor, which then induces the ultimate cellular response to the original 
extracellular stimulus. There are more complex systems involving such histidine kinases in which 
there are multiple phosphoryl transfers between the histidine kinase and the response regulator 
protein in a phosphorelay system involving proteins/domains in which phosphoryl transfer occurs 
alternately to aspartate and histidine (see Fig. 3 in Attwood, 20133). These systems occur in plants 
and fungi, as well as bacteria. It is the thermodynamic instability of phosphohistidine (as well as 
that of phosphoaspartate ± a phosphoanhydride) compared to the phosphoester phosphoamino acids 
that facilitates these phosphoryl transfer reactions (Table 1). In addition, in bacteria, Lu et al. 
showed that NDP kinase was capable of phosphorylating histidine residues in the two-component 
histidine kinases EnvZ and CheA in Escherichia coli.4 However, since this phosphorylation only 
occurred when ADP was present in the reaction mixture, Levit et al demonstrated that, independent 
of any protein-protein phosphotransfer mechanism by NDPK, contaminating ADP in the reactions 
(and NDP kinase) may have been responsible for generation of 32P-ATP required for 
autophosphorylation of the bacterial His kinases.5  
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Another system in bacteria that involves histidine phosphorylation is the 
phosphoenolpyruvate/sugar phosphotransferase system in which a phosphoryl group initially 
derived from phosphoenolpyruvate, and following transfer between different protein components of 
the system, is finally used for phosphorylation of the transported sugar molecule6.  
  
(ii) Animals 
This type of phosphoryl transfer between proteins does not appear to occur in animal signalling 
systems that use Ser/Thr and Tyr protein kinases. Nor is there any direct evidence of the occurrence 
of two-component histidine kinase systems in animals, although as noted by Attwood (2013),3 there 
are a number of animal proteins in sequence databases that contain the conserved amino acid 
sequences associated with both histidine kinase and response regulator proteins in two-component 
histidine kinase systems. What little is known about protein phosphorylation by histidine kinases in 
animals suggests that the main purpose of this form of phosphorylation is similar to that in the 
Ser/Thr and Tyr kinase systems i.e. changing protein activity and possibly protein-protein 
interaction (see below).  
If protein histidine phosphorylation is playing similar roles to serine, threonine and tyrosine 
phosphorylation in animals, one would expect there to be one or more phosphatases to catalyse the 
dephosphorylation of phosphohistidine-containing phosphoproteins. In fact, there is some question 
as to the requirement for a specific protein phosphohistidine phosphatase (PHP) since it has been 
shown that some protein phosphoserine/phosphothreonine phosphatases are also very efficient 
PHPs, e.g. PP1, PP2A and PP2C.7, 8  However, a mammalian PHP (or PHPT1) has been 
discovered9, 10 that shows high specificity towards proteins and peptides containing 
phosphohistidine and no activity towards peptides containing phosphoserine, phosphothreonine or 
phosphotyrosine6.  Later though, PHPT1 was found to have a somewhat wider specificity, as it was 
also found to catalyse the hydrolysis of phosphoramidate11 and also phospholysine, but not 
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phosphoarginine12.  A number of metabolic enzymes do make use of the thermodynamic instability 
of phosphohistidine to catalyse phosphoryl transfer reactions via an enzymic, active site 
phosphohistidine intermediate e.g. phosphoglycerate mutase13 ATP-citrate lyase14 and nucleoside 
diphosphate kinase (NDPK)15.  It has been suggested that the apparent phosphorylation of both 
succinate thiokinase and ATP-citrate lyase by NDPK16, 17 may be explained as autophosphorylation 
events in these enzymes since both enzymes have a reactive histidine residue in their active sites 
which undergoes autophosphorylation in the course of their normal catalytic cycles.5, 18  However, 
this does not explain the histidine phosphorylation of aldolase C by Nm23-H1 or rat liver NDPK19 
and other mammalian proteins as detailed below. 
 
Animal Protein Histidine Kinases 
(i) Histone H4 Histidine Kinase(s) 
Amongst the earliest described animal (mammalian) histidine kinases is histone H4 histidine 
kinase. This was discovered in regenerating rat liver nuclei20, 21 and in Walker 256 carcinosarcoma 
cells22. Later, it was shown that a similar histone H4 histidine kinase was present in porcine thymus 
nuclei23 and in human hepatocellular carcinoma tissue and human foetal liver 17 Histone H4 
histidine kinase activity was also found in Physarum polycephalum24 and Saccharomyces 
cerevisiae25. Thus, this histidine kinase activity is associated with cellular proliferation in normal 
and cancerous cells, however it is not clear how histone H4 histidine phosphorylation is linked to 
these process. In addition, a histone H4 histidine kinase has never been fully characterized and 
identified from any source. 
 
(ii) Nucleoside Diphosphate Kinase 
NDPK is normally regarded to fulfill a metabolic role in cells by maintaining the balance of 
nucleoside triphosphates by catalyzing the transfer of a phosphoryl group from a nucleoside 
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triphosphate (most commonly ATP) to a nucleoside diphosphate via an active site phosphohistidine 
intermediate (Fig. 2). Recently however, the -A and -B isoforms of NDPK have been reported to act 
protein histidine kinases, in which the phosphoryl group from the active site phosphohistidine of 
NDPK is transferred to a histidine residue in another protein. NDPK-A has been reported to 
phosphorylate ATP-citrate lyase26 and annexin A1 27, 28 whilst NDPK-B phosphorylates the beta 
subunit of trimeric G-proteins, 29 the potassium channel ± KCa3.130 and the calcium channel ± 
TRPV5.31    
 
Histidine phosphorylation and TRPV5 calcium channels 
Cai et al provided evidence that TRPV5 is regulated by reversible histidine phosphorylation 31.  The 
authors demonstrated that NDPK-B, but not NDPK-A, regulates the epithelial Ca2+ channel the 
transient receptor potential-vanilloid-5 (TRPV5); activation of TRPV5 requires phosphorylation of 
His711 in the C-terminus by NDPK-B whereas dephosphorylation by PHPT1 inactivated the 
channel.  Furthermore, knockdown of NDPK-B by siRNA resulted in decreased TRPV5 channel 
activity, and in addition, NDPK-Bíí mice fed a high-Ca2+ diet showed increased urinary Ca2+ 
excretion.  The findings that NDPK-B and PHPT1 regulate TRPV5 and Ca2+ reabsorption support 
the idea that reversible histidine phosphorylation plays many important but as yet-unknown roles in 
mammalian cellular function. 
 
NDPK and tumour metastasis suppression 
In the early 1990s, it became evident that enhanced cancer metastasis was linked to reduced 
expression of a gene named nm23, which turned out to be identical to human Nme1, also called 
Nm23-H1 or NDPK-A. Differential expression of Nme1 was found in experimental melanoma 
metastasis whereby Nme1 was more highly expressed in poorly metastatic sublines of the K-1735 
murine melanoma than in related, highly metastatic sublines.32  Transfection of Nme1 into a highly 
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metastatic melanoma line significantly reduced metastasis but had no effect on primary tumor 
size.33  The metastasis suppressor activity of Nme1 has been demonstrated in many cancers except 
leukemias, lymphomas, and neuroblastoma.34, 35  Multiple aspects of metastasis have been 
implicated in Nme1 suppression including cell adhesion36-38, motility and signalling39-45, and 
proteolysis46.  As discussed by Kaetzel et al. 2014, Nme1 promotes genomic stability in melanoma 
through direct interactions with at least two DNA repair pathways, nucleotide excision repair and 
double-strand break repair.38  However, to date, the mechanism and function of Nme1 underlying 
its tumor metastasis suppressor activity remains to be established.  
The question of which of the biological activities of Nme1 is associated with suppression of 
metastasis has been the subject of investigation over a number of years. Freije et al.47 and Wagner 
et al.48 used the approach of examining the effects of overexpression of wild-type and site-directed 
mutant forms of Nme1on human breast carcinoma cell motility. Freije et al.47 showed that the loss 
of protein kinase activity in the two mutants (P96S and S120G) correlated with the inability of these 
mutants to suppress cell motility.  Both of these mutant forms of Nme1 retained normal 
autophosphorylating activity47. Wagner et al.48showed that the failure of these two mutant forms of 
Nme1 to suppress motility was most strongly correlated with a reduced ability to phosphorylate 
glutamate or aspartate residues on a 43 kDa protein from bovine brain rather than the ability to 
phosphorylate histidine residues on succinate thiokinase or ATP-citrate lyase. Later work by 
Hartsough et al.40, associated the metastasis suppressor activity of Nme1 with its ability to 
phosphorylate the kinase suppressor of Ras on serine residues. More recently, Wu et al.49 showed 
that two serine mutants of Nme1 (S44A and S120G) were unable to suppress tyrosine 
phosphorylation of STAT3 which is involved in the upregulation of expression of metalloproteinase 
9, an important metastatic factor. However, the H118F mutant of Nme1 still maintained the ability 
to suppress STAT3 phosphorylation. In this instance at least, the autophosphorylation ability and 
protein kinase function of Nme1 does not appear to be directly connected with the effect on STAT3 
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phosphorylation. Thus much remains to be investigated concerning the relationship between the 
protein kinase activity of Nme1 in general, and its protein histidine kinase activity in particular, and 
its anti-metastatic effect. 
 
Histidine phosphorylation and Ca2+-activated potassium channels 
KCa3.1 is a Ca
2+-activated K+ channel of an intermediate conductance which is expressed in T and B 
cells, smooth muscle and epithelial cells. The channel functions to keep a negative membrane 
potential by mediating the efflux of K+, which is required to maintain a favourable electrochemical 
gradient for Ca2+ influx.  Activation of KCa3.1 requires not only binding of phosphatidylinositol 3-
phosphate PI(3)P and Ca2+/calmodulin to 14 amino acids in the carboxyl terminus but also 
phosphorylation by nucleoside diphosphate kinase (NDPK-B) at His358 in the same cytoplasmic 
domain 30, 50. Among the four calcium-activated KCa potassium channels (KCa2.1, KCa2.2, KCa2.3 
and KCa3.1; also called SK1±4), KCa3.1 is unique as it possesses a His residue at 358, which 
requires phosphorylation for activation. Using a yeast two-hybrid library screen, Srivastava et al, 
demonstrated binding of NDPK-B to the 14 amino acids carboxyl terminus of KCa3.1 and showed 
that phosphorylation of H358 of KCa3.1 regulates its activation in CD4
+ T cells.30  The specificity 
and relevance of the NDPK-B/ KCa3.1 interaction was confirmed by biochemical, molecular and 
functional approaches: a) immunoprecipitation involving endogenous NDPK-B and KCa3.1 proteins 
in human CD4+ T cells, b) whole-cell patch-clamp experiments showing increased amplitude in 
CHO cells overexpressing NDPK-B and KCa3.1 proteins, c) NDPK-B knockdown showed 
inhibition of KCa3.1 channel activity, Ca
2+ influx and proliferation of human CD4+ T cells.  
Srivastava et al have also demonstrated that the protein histidine phosphatase PHPT1 
dephosphorylates pHis 358 of KCa3.1 leading to negative regulation of CD4
+ T cells.51  
Interestingly, that PHPT1 failed to dephosphorylate autophosphorylated NDPK-B (pHis118) 52 
provided evidence for the potential existence of other PHPs apart from Ser/Thr phosphatases that 
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can also randomly dephosphorylate pHis proteins as shown by a previous report.7  In this regard, 
Panda et al. recently provided confirmation that other phosphatases exist that may specifically 
interact with and target phosphohistidine residues on particular proteins via specific binding motifs; 
they showed that phosphoglycerate mutase 5 (PGAM5) dephosphorylates NDPK-B 
autophosphorylated on H118, thereby inhibiting subsequent phosphorylation and activation of 
KCa3.1 and resulting in decreased TCR-mediated Ca
2+ influx and proinflammatory cytokine 
production in CD4+ T cells. 53  These authors also observe that PGAM5 function as a histidine 
phosphatase is restricted to NDPK-B pHis 118 and that a 12 aa motif N-terminal to the PGAM 
domain mediates binding to NDPK-B, but PGAM is unable to dephosphorylate NDPK-A pHis118 
or the KCa3.1 pHis358 and inhibit its activity; both NDPK-A and KCa3.1 lack the cognate motif for 
PGAM5 (conversely NDPK-B lacks the binding motif for PHPT1)51.  Although counterintuitive at 
first glance, since the 3D - structure of human NDPK-A/ADP shows only a single NTP/NDP 
binding,54 this suggests that phosphorylated His118 in the NDPK active site is exposed and 
accessible to PGAM5.  It is worth noting that PGAM5 belongs to the histidine phosphatase 
superfamily, a large functionally diverse group of proteins that share a common catalytic domain, 
designated as the PGAM domain and functions as phosphotransferases and/or phosphohydrolases; 
and share a conserved catalytic core centred on a histidine which becomes phosphorylated during 
the course of the reaction.55 Most members of the superfamily possess phosphoglycerate mutase 
activity and are involved in regulating glucose metabolism. On the other hand, some family 
members such as PGAM5, which do not possess PGAM activity, have been shown to function as 
protein phosphatases specific for phospho-Ser/Thr (pSer/pThr) residues. Thus, Panda et al provide 
evidence for transfer of phosphate from the autophosphorylated NDPK-B H118 active site and 
subsequent phosphorylation of His105 within the PGAM5 active site.53  However, the reaction 
stoichiometry is unclear from this study and whether the transferred phosphate is retained for 
further relay to yet-unknown target(s) or finally released as Pi; nonetheless, the study provides more 
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evidence for His/His phospho-relay signalling networks, largely underappreciated in eukaryotic 
systems.  Additionally, it is also as yet unclear whether PGAM5-activity against pSer/Thr results in 
similar phosphorylation of PGAM at H105 or Pi release, since phosphoester bonds have low Delta 
G degrees of hydrolysis, compared to the phosphoramidate (P-N) bond of phosphohistidine (Table 
1). 
 
NDPK and CFTR chloride channels 
In epithelia, chloride (Cl-) channels play a prominent role in fluid and electrolyte transport. Of 
particular importance is the cystic fibrosis (CF) transmembrane conductance regulator Cl- channel 
(CFTR, a cAMP/ATP and/or GTP regulated chloride channel) with mutations of the CFTR 
encoding gene causing cystic fibrosis. Using a two-hybrid screen and immunoprecipitation analysis, 
Klein et al recently provide evidence that CFTR and KCa3.1 can exist in a dynamic complex in 
epithelia and demonstrate that physical interaction occurs between cytosolic domains of both 
proteins; both the N-terminal fragment M1-M40 and part of the calmodulin binding domain 
(residues L345-A400) of KCa3.1 were found to interact with the nucleotide binding domain NBD2 
segment (G1237-Y1420) and C- terminal region of CFTR (residues T1387- L1480) 56.    
Previous work demonstrated that in apical membranes from airway epithelia, NDPK histidine 
phosphorylation is regulated by both chloride and cation concentration in vitro and provided 
evidence not only for NDPK involvement but for potential His/His phospho-relay signalling in 
chloride secretion and epithelial function27, 28, 57. 
Although NDPK-A and B have previously been shown to exist as a heterohexamer, increasing 
evidence suggests that despite their highly homologous nature (and their genes lie adjacent to one 
another), the cellular actions of NDPK-A and -B isoforms differ substantially in airway epithelia.  
For example, NDPK-B is predominantly cytosolic in airway epithelia while NDPK-A is present in 
both the cytosol and membrane fractions 58.  The precise distinction between cytosolic and 
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particulate NDPK-A is as yet unknown but recent evidence also shows that membrane bound 
NDPK-A interacts with AMP-activated protein kinase (AMPK) 59, 60.  Although both NDPK-A and 
AMPK exist in the cytosol and membrane compartments, the two proteins do not always exist in a 
complex in epithelia suggesting the existence of a specific mechanism or post-translational 
modification and/or binding partner (unpublished observations).  
Interestingly, both NDPK-A and B interact with CFTR either directly or indirectly through 
associated proteins 58, 60.  This interaction with CFTR occurs independently of each isoform, by 
different mechanisms and with different cellular end points.  King et al provided evidence that 
NDPK-A, AMPK, and CFTR exist in a plasma membrane-associated complex in airway epithelia, 
whereby AMPK phosphorylates CFTR and inhibits PKA-stimulated CFTR channel gating. 
Although the precise mechanisms remain unclear, it was observed that a) AMPK catalytic function 
enhances NDPK-A auto-phosphorylation at His-118 in vitro, b) Xenopus oocytes co-expressing 
AMPK and CFTR with wild type, but not the NDPK-A catalytically inactive H118F mutant or 
various Ser-120 NDPK-A mutants, inhibit CFTR conductance in two-electrode voltage clamp 
studies indicating that NDPK-A catalytic function plays an integral role in the inhibition of CFTR 
by AMPK.60  The observation that AMPK enhances NDPK-A auto-phosphorylation is in agreement 
with a previous work in human bronchial epithelial cell line 16HBE14o- (enhancement does not 
occur in CF bronchial epithelial cells (CFBE41o±) cell lines 59, 61. In contrast, others have provided 
evidence that during nutrient stress, AMPK phosphorylates NDPK at S120, thereby mediating 
inhibition of NDPK activity. AMPK is a key energy sensor that regulates metabolism to maintain 
cellular energy balance 62. 7KH IXQFWLRQDO LQWHUDFWLRQEHWZHHQ&)75$03.ĮDQG1'3.-A, is 
independent of NDPK-B. 
Following cAMP/PKA activation, NDPK-B translocates from the cytosol to the apical membrane in 
airway epithelia to form a functionally relevant complex with CFTR. The precise mechanism 
leading to NDPK-B relocation to the apical membrane is still unclear but interaction with CFTR 
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occurs through a distinct domain of NDPK-B involving amino acids 36 - 56 while the nucleotide 
binding domain 1 (NBD1, aa 351± 727) of CFTR constitutes an NDPK-B interaction site. 
Interestingly, although both CFTR and NDPK-B exist in other cellular compartments, the 
cAMP/PKA induced interaction is restricted to the apical membrane and highlights a particular role 
for NDPK-B in epithelial cell chloride secretion.  A peptide derived from NDPK-B 36±54 aa 
sequence, but not its NDPK-A equivalent, not only disrupts the interaction between NDPK-B and 
CFTR but also reduces chloride currents in epithelia.   
 
Histidine phosphorylation and heterotrimeric G-protein signalling 
Stimulated G-protein±coupled receptors (GPCRs) catalyze the exchange of guanosine triphosphate 
(GTP) for guanosine diphosphate (GDP) and the dissociation of the G-protein heterotrimer, 
allowing both the GTP-ERXQG*ĮVXEXQLWDQGIUHHȕJ complexes to signal to downstream effectors 
including adenylate cyclase, phosphodiesterase, phospholipase C or ion channels to bring about a 
wide variety of physiological processes. Recent evidence shows that His/His phospho-relay 
signalling provides an alternative receptor-independent way of heterotrimeric G protein activation 
29, 63.  NDPK-B, but not NDPK-$ IRUPV FRPSOH[HV ZLWK *ȕȖ UHVXOWLQJ LQ phosphorylation of 
KLVWLGLQH UHVLGXH +LV RQ WKH * SURWHLQ ȕ VXEXQLW RI KHWHURWULPHULF * SURWHLQV DQG OHDGLQJ WR
formation of GTP and to an increase in cAMP synthesis.  Cells expressing an inactive NDPK-B 
mutant (H118N) exhibit decreased cAMP formation.  In cardiomyocytes, heterotrimeric G proteins 
are key regulators of myocardial contractility. SiRNA-mediated NDPK-B knockdown and 
RYHUH[SUHVVLRQRIDȕJ-dimer mutant carrying a single amino acid substitution at His-LQWKHȕ
VXEXQLW*ȕ+/J2) led to reduced receptor-LQGHSHQGHQW*ĮVDFWLYDWLRQVXSSUHVVHGEDVDOF$03
formation and basal contractility in intact cardiomyocytes 64.  +RZHYHUWKHȕ-DGUHQRFHSWRUȕ$5
agonist isoproterenol-LQGXFHGLQFUHDVHLQF$03IRUPDWLRQZDVQRWDIIHFWHGE\*ȕ+/J2.  
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Mäurer et al have also demonstrated that eukaryotic phosphohistidine phosphatase (PHP, also 
called PHPT1) specifically dephosphoryODWHV *ȕ S+LV EXW QRW NDPK-B (pHis118), in 
reconstituted systems and in H10 cells membranes 65 suggesting that PHPT1 might be a candidate 
for an endogenous regulator of basal NDPK-dependent G protein activation. It has also been 
observed that in plasma membranes of hearts from patients with severe congestive heart failure, but 
QRW LQSDWLHQWV WUHDWHGZLWK Dȕ$5DQWDJRQLVW D -fold elevated content and activity of NDPK is 
detected and that chronic treatment of rats with isoproterenol, induces an increase in plasma 
membrane bound NDPK-B 66, 67.  This suggests that NDPK-B membrane content may be under the 
FRQWURORIȕ-adrenergic signalling and that NDPK may play an important role in heart failure and 
hypertrophy. Abu-Taha et al show that NDPK-C-mediates targeting of NDPK-A and -B isoforms to 
the plasma membrane and formation of the NDPK-B/G proteins complex in cardiomyocytes and is 
WKXVDFULWLFDOUHJXODWRURIȕ-adrenoceptor/cAMP signaling and cardiac contractility 68. 
 
In conclusion, currently the well-studied cellular functions of NDPKs as protein kinases is the 
regulation of G protein activation and of ion channels by NDPK-B.  Among the important questions 
that remain to be addressed is how NDPK can function both as a nucleoside phosphotransferase and 
a histidine protein kinase. The crystal structure of human NDPK-A/ADP shows a single NTP/NDP 
binding pocket that in this conformation does not appear to be accessible to protein substrates.54 It 
has been suggested that residues of the substrate proteins of NDPK may play a role in catalyzing 
phosphoryl transfer from pHis118 of NDPK-B and in this regard, Attwood and Wieland have 
recently suggested various models of structures of NDPK-B and target proteins.6  However, it is 
also clear that other as yet uncharacterised protein factors are required for interaction and 
phosphoryl transfer to occur.29, 30, 68  
In view of the high sequence similarity between NDPK-A to C (66-88%)26, protein-protein 
interactions most likely form the basis for target selection and distinction between the various 
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NDPKs.  As demonstrated for CFTR, KCa3.1 and PGAM5 binding with NDPK-B, the notion that 
protein-protein interactions modulate the specific molecular actions of NDPK59 remains current and 
is likely to grow in importance particularly as more targets for NDPKs are identified, e.g. by new 
advances in phosphohistidine proteomics69, 70.  
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Figure Legends 
 
Figure 1. Structures of the side chains of: a. phosphoserine; b. phosphothreonine; c. 
phosphotyrosine; d. 1-phosphohistidine; e. 3-phosphohistidine; f. phosphoaspartate. 
 
 
Figure 2 The reaction mechanism of the normal metabolic reaction catalyzed by NDPK. This 
shows the initial transfer of gamma phosphoryl group from a nucleoside triphosphate (XTP) to a 
histidine residue in the active site of NDPK, (NDPK-His) to form NDPK-phosphohistidine (NDPK-
His-P) and XDP. The nucleoside diphosphate (YDP) then binds in the active site of NDPK and the 
phosphoryl group is transferred to it from the phosphohistidine to YDP to form YTP. 
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